Clin2
NCT07168434Possibly a fitRecruiting

Yeast supplement for irritable bowel syndrome (IBS)

IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)IBS, Mixed Symptoms

Part of Digestive system, Genetic & congenital, Skin clinical trials.

This trial tests if a yeast supplement called Saccharomyces boulardii can help people with irritable bowel syndrome (IBS), except for those with constipation as their main symptom. Participants take the supplement and see if their symptoms improve.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
406 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have been diagnosed with IBS (any type except the constipation-only type) according to standard criteria.
  • Your IBS symptoms are moderate to severe (score of 175 or higher on a symptom scale).
  • You are willing to keep your usual diet during the study.
  • You agree to avoid certain other medicines like antibiotics, laxatives, and probiotics while participating.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06760533Not yet recruiting· Early Phase 1
Psilocybin therapy for irritable bowel syndrome

This trial tests whether psilocybin-assisted psychotherapy can help people with severe irritable bowel syndrome (IBS) who have not gotten better with standard treatments. Psilocybin is a psychedelic substance that may help reset brain-gut connections to reduce symptoms.

New York, New York
NCT07238790Not yet recruiting· Early Phase 1
Bacteria treatment for diarrhea-type irritable bowel syndrome

This trial tests a new treatment made from a mix of bacteria that live in the gut. It aims to improve symptoms of irritable bowel syndrome with diarrhea (IBS-D) in people who have certain gut bacteria imbalances.

Redwood City, California
NCT07475299Not yet recruiting
Gut health supplement for irritable bowel syndrome

This study tests a daily supplement containing beneficial bacteria (synbiotic) and plant extracts to improve gut health and reduce symptoms of irritable bowel syndrome (IBS), such as bloating, gas, and changes in bowel habits. It lasts about 16 weeks and involves taking the supplement and providing blood and stool samples.

Cluj-Napoca
NCT07235228Recruiting
Synbiotic supplement for irritable bowel syndrome

This trial tests whether a synbiotic (a mix of probiotics and prebiotics) called Vivatlac can improve gut health in people with moderate to severe irritable bowel syndrome (IBS). If you have IBS and are not already taking probiotics or antibiotics, you may be able to join.

Jarocin
NCT07872514Enrolling by invitation
Personalized probiotics for irritable bowel syndrome

This study tests whether a probiotic treatment designed specifically for you can help ease your irritable bowel syndrome (IBS) symptoms. If you make it into the study, you'll get a treatment plan tailored to your gut and your symptoms.

Hamilton, Ontario
NCT07039747Recruiting· Phase 2
Can a dietary supplement help people with irritable bowel syndrome?

This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.

Rouen, France

Hear when a new IBS-D (Diarrhea-predominant) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.